Chronic Myeloid Leukemia -2023 Best of Hematology Conference
In this session, Dr Michael Deininger from University of Utah provides relevant updates on chronic myeloid leukemia from this year’s meetings.
▶︎
Acute Lymphoblastic Leukemia and Acute Myeloid Leukemia - 2023 Best of Hematology Conference
▶︎
#3 2025 08 23 Cancer Center Lynch Syndrome Symposium Preventing Cancers in Lynch Syndrome
▶︎
JCO at ASCO 2026: Pemigatinib Phase 3 FIGHT-302 Trial in Cholangiocarcinoma
▶︎
Imaging Informatics
▶︎
Innovations in Myeloma Therapies: Promise of ADCs, CELMoDs, BCL2 Inhibitors, & SINEs | Dan Vogl, MD
▶︎
How Long Can I Live with CLL? (Chronic Lymphocytic Leukemia) | The Patient Story
![Anterior & Intermediate Uveitis: A Practical Approach for the Comprehensive Eye Providers [ARCHIVE]](https://i.ytimg.com/vi/RObkiMZL_oY/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLDZaw8IFlBMFaIz4rc3YKQuZ0iDBA)
▶︎
Anterior & Intermediate Uveitis: A Practical Approach for the Comprehensive Eye Providers [ARCHIVE]
▶︎
𝗨𝗻𝘃𝗲𝗶𝗹𝗶𝗻𝗴 𝘁𝗵𝗲 𝗜𝗻𝘃𝗶𝘀𝗶𝗯𝗹𝗲:𝗛𝗼𝘄 𝗘𝗳𝗳𝗲𝗰𝘁 𝗕𝗮𝘀𝗲𝗱 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀 𝗧𝗿𝗮𝗻𝘀𝗳𝗼𝗿𝗺 𝗢𝘂𝗿 𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗼𝗳 𝗖𝗵𝗲𝗺𝗶𝗰𝗮𝗹 𝗠𝗶𝘅𝘁𝘂𝗿𝗲𝘀
▶︎
Personalized Medicine in Ovarian Cancer – Pier Paolo Claudio, MD
▶︎
Updates in Non Prostate Urogenital Cancers - Sandy Srinivas, MD
![Bilateral Optic Neuritis [ARCHIVE]](https://i.ytimg.com/vi/u1Tn4bYk6CE/hqdefault.jpg?sqp=-oaymwEjCNACELwBSFryq4qpAxUIARUAAAAAGAElAADIQj0AgKJDeAE=&rs=AOn4CLDtDQYIi5b9Uhho8pn2MLsajmRTBg)
▶︎
Bilateral Optic Neuritis [ARCHIVE]
▶︎
Hepatology and Liver Transplantation | Approach to Alcohol Use in the Context of Transplantation
▶︎
Cut Your Stroke Risk Dramatically by Preventing AFib
▶︎
Upright Activity and Exercise Intolerance: Critical Concepts in the Evaluation of Chronic Fatigue
▶︎
The new medical innovations that could change everything - The Engineers, BBC World Service
▶︎
Ovarian Cancer 101
▶︎
JCO at ASCO 2026: Intravesical Recombinant BCG with Chemo-Immunotherapy in MIBC
▶︎
2026 - MS - Tracking BRAF V600E Persistence in Histiocytoses - Julien Haroche
▶︎
AI Is Creating A Rare Opportunity For Investors. How Jim Roppel Is Playing It. | Investing With IBD
▶︎